These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 34127063

  • 1. Reversible GABAergic dysfunction involved in hippocampal hyperactivity predicts early-stage Alzheimer disease in a mouse model.
    Li Y, Zhu K, Li N, Wang X, Xiao X, Li L, Li L, He Y, Zhang J, Wo J, Cui Y, Huang H, Zhang J, Wang W, Wang X, Zheng Y.
    Alzheimers Res Ther; 2021 Jun 14; 13(1):114. PubMed ID: 34127063
    [Abstract] [Full Text] [Related]

  • 2. Reduction of Dendritic Inhibition in CA1 Pyramidal Neurons in Amyloidosis Models of Early Alzheimer's Disease.
    Ruiter M, Herstel LJ, Wierenga CJ.
    J Alzheimers Dis; 2020 Jun 14; 78(3):951-964. PubMed ID: 33074225
    [Abstract] [Full Text] [Related]

  • 3. Impairment of Spike-Timing-Dependent Plasticity at Schaffer Collateral-CA1 Synapses in Adult APP/PS1 Mice Depends on Proximity of Aβ Plaques.
    Garad M, Edelmann E, Leßmann V.
    Int J Mol Sci; 2021 Jan 30; 22(3):. PubMed ID: 33573114
    [Abstract] [Full Text] [Related]

  • 4. Early alterations in hippocampal perisomatic GABAergic synapses and network oscillations in a mouse model of Alzheimer's disease amyloidosis.
    Hollnagel JO, Elzoheiry S, Gorgas K, Kins S, Beretta CA, Kirsch J, Kuhse J, Kann O, Kiss E.
    PLoS One; 2019 Jan 30; 14(1):e0209228. PubMed ID: 30645585
    [Abstract] [Full Text] [Related]

  • 5. BHBA treatment improves cognitive function by targeting pleiotropic mechanisms in transgenic mouse model of Alzheimer's disease.
    Wu Y, Gong Y, Luan Y, Li Y, Liu J, Yue Z, Yuan B, Sun J, Xie C, Li L, Zhen J, Jin X, Zheng Y, Wang X, Xie L, Wang W.
    FASEB J; 2020 Jan 30; 34(1):1412-1429. PubMed ID: 31914599
    [Abstract] [Full Text] [Related]

  • 6. NMDA receptors mediate synaptic depression, but not spine loss in the dentate gyrus of adult amyloid Beta (Aβ) overexpressing mice.
    Müller MK, Jacobi E, Sakimura K, Malinow R, von Engelhardt J.
    Acta Neuropathol Commun; 2018 Oct 23; 6(1):110. PubMed ID: 30352630
    [Abstract] [Full Text] [Related]

  • 7. Amyloid-Beta1-42 -Induced Increase in GABAergic Tonic Conductance in Mouse Hippocampal CA1 Pyramidal Cells.
    Calvo-Flores Guzmán B, Kim S, Chawdhary B, Peppercorn K, Tate WP, Waldvogel HJ, Faull RL, Montgomery J, Kwakowsky A.
    Molecules; 2020 Feb 06; 25(3):. PubMed ID: 32041202
    [Abstract] [Full Text] [Related]

  • 8. Genetic reductions of beta-site amyloid precursor protein-cleaving enzyme 1 and amyloid-beta ameliorate impairment of conditioned taste aversion memory in 5XFAD Alzheimer's disease model mice.
    Devi L, Ohno M.
    Eur J Neurosci; 2010 Jan 06; 31(1):110-8. PubMed ID: 20092558
    [Abstract] [Full Text] [Related]

  • 9. Hippocampal hyperactivity in a rat model of Alzheimer's disease.
    Sosulina L, Mittag M, Geis HR, Hoffmann K, Klyubin I, Qi Y, Steffen J, Friedrichs D, Henneberg N, Fuhrmann F, Justus D, Keppler K, Cuello AC, Rowan MJ, Fuhrmann M, Remy S.
    J Neurochem; 2021 Jun 06; 157(6):2128-2144. PubMed ID: 33583024
    [Abstract] [Full Text] [Related]

  • 10. Non-fibrillar beta-amyloid abates spike-timing-dependent synaptic potentiation at excitatory synapses in layer 2/3 of the neocortex by targeting postsynaptic AMPA receptors.
    Shemer I, Holmgren C, Min R, Fülöp L, Zilberter M, Sousa KM, Farkas T, Härtig W, Penke B, Burnashev N, Tanila H, Zilberter Y, Harkany T.
    Eur J Neurosci; 2006 Apr 06; 23(8):2035-47. PubMed ID: 16630051
    [Abstract] [Full Text] [Related]

  • 11. Butyrylcholinesterase-knockout reduces fibrillar β-amyloid and conserves 18FDG retention in 5XFAD mouse model of Alzheimer's disease.
    DeBay DR, Reid GA, Macdonald IR, Mawko G, Burrell S, Martin E, Bowen CV, Darvesh S.
    Brain Res; 2017 Sep 15; 1671():102-110. PubMed ID: 28729192
    [Abstract] [Full Text] [Related]

  • 12. Loss of Hippocampal Calretinin and Parvalbumin Interneurons in the 5XFAD Mouse Model of Alzheimer's Disease.
    Giesers NK, Wirths O.
    ASN Neuro; 2020 Sep 15; 12():1759091420925356. PubMed ID: 32423230
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Inhibitory Parvalbumin Basket Cell Activity is Selectively Reduced during Hippocampal Sharp Wave Ripples in a Mouse Model of Familial Alzheimer's Disease.
    Caccavano A, Bozzelli PL, Forcelli PA, Pak DTS, Wu JY, Conant K, Vicini S.
    J Neurosci; 2020 Jun 24; 40(26):5116-5136. PubMed ID: 32439703
    [Abstract] [Full Text] [Related]

  • 18. Dysregulated clock gene expression and abnormal diurnal regulation of hippocampal inhibitory transmission and spatial memory in amyloid precursor protein transgenic mice.
    Fusilier AR, Davis JA, Paul JR, Yates SD, McMeekin LJ, Goode LK, Mokashi MV, Remiszewski N, van Groen T, Cowell RM, McMahon LL, Roberson ED, Gamble KL.
    Neurobiol Dis; 2021 Oct 24; 158():105454. PubMed ID: 34333153
    [Abstract] [Full Text] [Related]

  • 19. Preservation of dendritic spine morphology and postsynaptic signaling markers after treatment with solid lipid curcumin particles in the 5xFAD mouse model of Alzheimer's amyloidosis.
    Maiti P, Bowers Z, Bourcier-Schultz A, Morse J, Dunbar GL.
    Alzheimers Res Ther; 2021 Feb 08; 13(1):37. PubMed ID: 33557949
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.